Schedule 13G ownership disclosure

LATIGO BIOTHERAPEUTICS

Common stock, par value $0.0001 per share · CUSIP: 517954103

Event date: 2026-09-03

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • AI Biotechnology LLC

    Shares: 3,193,565 · Class: 4.8%

  • Access Industries Holdings LLC

    Shares: 3,193,565 · Class: 4.8%

  • Access Industries Management, LLC

    Shares: 3,193,565 · Class: 4.8%

  • Len Blavatnik

    Shares: 3,193,565 · Class: 4.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-452089
Form type
SCHEDULE 13G/A
Filer
Latigo Biotherapeutics, Inc.
CIK
CIK 2056611
Filed
Nov 06, 2026
Reporting period
Sep 03, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub